US FDA, PTO Pulled Into Debate Over Patents And Drug Pricing

 
• By Brenda Sandburg
Drug prices
US FDA and USPTO asked to analyze data on patents and drug pricing • Source: Alamy

More from Legal & IP

More from Pink Sheet